Global disease detection—achievements in applied public health research, capacity building, and public health diplomacy, 2001–2016

Emerging Infectious Diseases

Volumn 23, Issue , 2017, Pages S138-S146

  Rao, Carol Y ^a   Goryoka, Grace W ^a   Henao, Olga L ^a,b   Clarke, Kevin R ^a   Salyer, Stephanie J ^a   Montgomery, Joel M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RESPIRATORY TRACT DISEASE; APPLIED RESEARCH; ARTICLE; DECISION MAKING; DISEASE SURVEILLANCE; EPIDEMIC; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; MEDICAL INFORMATICS; MEDICAL RESEARCH; PUBLIC HEALTH; RISK FACTOR; SALMONELLOSIS; VIRUS INFECTION; CAPACITY BUILDING; COMMUNICABLE DISEASE; DIPLOMACY; GLOBAL HEALTH; HEALTH SERVICES RESEARCH; HEALTH SURVEY; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLIC HEALTH SERVICE;

CAPACITY BUILDING; COMMUNICABLE DISEASES, EMERGING; DIPLOMACY; GLOBAL HEALTH; HEALTH SERVICES RESEARCH; HUMANS; POPULATION SURVEILLANCE; PUBLIC HEALTH; PUBLIC HEALTH ADMINISTRATION;

EID: 85038621756     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2313.170859     Document Type: Article

References (36)

1. US Centers for Disease Control and Prevention Emerging Infections Programs [cited 2016 Apr 8]. https://www.cdc.gov/ncezid/dpei/eip
2. Christian KA, Ijaz K, Dowell SF, Chow CC, Chitale RA, Bresee JS, et al. What we are watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection operations center. Emerg Health Threats J. 2013;6:20632. http://dx.doi.org/10.3402/ehtj.v6i0.20632
3. Breiman RF, Van Beneden CA, Farnon EC. Surveillance for respiratory infections in low- and middle-income countries: experience from the Centers for Disease Control and Prevention’s Global Disease Detection International Emerging Infections Program. J Infect Dis. 2013;208(Suppl 3):S167–72. http://dx.doi.org/10.1093/infdis/jit462
4. Shrivastava A, Kumar A, Thomas JD, Laserson KF, Bhushan G, Carter MD, et al. Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study. Lancet Glob Health. 2017;5:e458–66. http://dx.doi.org/10.1016/S2214-109X(17)30035-9
5. Haque F, Kundu SK, Islam MS, Hasan SM, Khatun A, Gope PS, et al. Outbreak of mass sociogenic illness in a school feeding program in northwest Bangladesh, 2010. PLoS One. 2013;8:e80420. http://dx.doi.org/10.1371/journal.pone.0080420
6. Haynes AK, Manangan AP, Iwane MK, Sturm-Ramirez K, Homaira N, Brooks WA, et al. Respiratory syncytial virus circulation in seven countries with Global Disease Detection regional centers. J Infect Dis. 2013;208(Suppl 3): S246–54. http://dx.doi.org/10.1093/infdis/jit515
7. Zaman K, Yunus M, El Arifeen S, Azim T, Faruque AS, Huq E, et al. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh. Vaccine. 2012;30(Suppl 1):A94–100. http://dx.doi.org/10.1016/j.vaccine.2011.07.117
8. Omore R, Osawa F, Musia J, Rha B, Ismail A, Kiulia NM, et al. Intussusception cases among children admitted to referral hospitals in Kenya, 2002–2013: implications for monitoring postlicensure safety of rotavirus vaccines in Africa. J Pediatric Infect Dis Soc. 2016;5:465–9. http://dx.doi.org/10.1093/jpids/piv051
9. US Centers for Disease Control and Prevention. Infographic: Global Disease Detection: advancing the science of global public health [cited 2017 Apr 18]. https://www.cdc.gov/globalhealth/infographics/global_disease_detection.htm
10. Piralam B, Tomczyk SM, Rhodes JC, Thamthitiwat S, Gregory CJ, Olsen SJ, et al. Incidence of pneumococcal pneumonia among adults in rural Thailand, 2006–2011: implications for pneumococcal vaccine considerations. Am J Trop Med Hyg. 2015;93:1140–7. http://dx.doi.org/10.4269/ajtmh.15-0429
11. Yu H, Huang J, Huai Y, Guan X, Klena J, Liu S, et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012. Influenza Other Respi Viruses. 2014;8:53–65. http://dx.doi.org/10.1111/irv.12205
12. Verani JR, McCracken J, Arvelo W, Estevez A, Lopez MR, Reyes L, et al. Surveillance for hospitalized acute respiratory infection in Guatemala. PLoS One. 2013;8:e83600. http://dx.doi.org/10.1371/journal.pone.0083600
13. Rowlinson E, Dueger E, Taylor T, Mansour A, Van Beneden C, Abukela M, et al. Incidence and clinical features of respiratory syncytial virus infections in a population-based surveillance site in the Nile Delta Region. J Infect Dis. 2013;208(Suppl 3):S189–96. http://dx.doi.org/10.1093/infdis/jit457
14. Akhvlediani T, Bautista CT, Shakarishvili R, Tsertsvadze T, Imnadze P, Tatishvili N, et al. Etiologic agents of central nervous system infections among febrile hospitalized patients in the country of Georgia. PLoS One. 2014;9: e111393. http://dx.doi.org/10.1371/journal.pone.0111393
15. Ballah NJ, Kuonza LR, De Gita G, Musekiwa A, Williams S, Takuva S. Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003–2012: utility of laboratory-based information. Int J STD AIDS. 2017;28:564–72. http://dx.doi.org/10.1177/0956462416636727
16. US Centers for Disease Control and Prevention. Public health surveillance in the United States: evolution and challenges. MMWR Suppl. 2012;61:3–9.
17. Feikin DR, Njenga MK, Bigogo G, Aura B, Gikunju S, Balish A, et al. Additional diagnostic yield of adding serology to PCR in diagnosing viral acute respiratory infections in Kenyan patients 5 years of age and older. Clin Vaccine Immunol. 2013;20:113–4. http://dx.doi.org/10.1128/CVI.00325-12
18. Olsen SJ, Thamthitiwat S, Chantra S, Chittaganpitch M, Fry AM, Simmerman JM, et al. Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand. Epidemiol Infect. 2010;138:1811–22. http://dx.doi.org/10.1017/S0950268810000646
19. Brooks WA, Breiman RF, Goswami D, Hossain A, Alam K, Saha SK, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg. 2007;77:795–801.
20. Millman AJ, Greenbaum A, Walaza S, Cohen AL, Groome MJ, Reed C, et al. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting—South Africa, 2010–2011. BMC Pulm Med. 2017;17:28. http://dx.doi.org/10.1186/s12890-017-0368-8
21. Horton KC, Dueger EL, Kandeel A, Abdallat M, El-Kholy A, Al-Awaidy S, et al. Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007–2014. PLoS One. 2017;12:e0180954. http://dx.doi.org/10.1371/journal.pone.0180954
22. McCracken JP, Prill MM, Arvelo W, Lindblade KA, López MR, Estevez A, et al. Respiratory syncytial virus infection in Guatemala, 2007–2012. J Infect Dis. 2013;208(Suppl 3):S197–206. http://dx.doi.org/10.1093/infdis/jit517
23. Pretorius MA, Tempia S, Walaza S, Cohen AL, Moyes J, Variava E, et al. The role of influenza, RSV and other common respiratory viruses in severe acute respiratory infections and influenza-like illness in a population with a high HIV sero-prevalence, South Africa 2012–2015. J Clin Virol. 2016;75:21–6. http://dx.doi.org/10.1016/j.jcv.2015.12.004
24. Vora NM, Li Y, Geleishvili M, Emerson GL, Khmaladze E, Maghlakelidze G, et al. Human infection with a zoonotic orthopoxvirus in the country of Georgia. N Engl J Med. 2015;372: 1223–30. http://dx.doi.org/10.1056/NEJMoa1407647
25. Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, Mutonga D, et al. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg. 2010;83(Suppl):14–21. http://dx.doi.org/10.4269/ajtmh.2010.09-0293
26. Knust B, Medetov ZB, Kyraubayev KB, Bumburidi Y, Erickson BR, MacNeil A, et al. Crimean-Congo hemorrhagic fever, Kazakhstan, 2009–2010. Emerg Infect Dis. 2012;18:643–5. http://dx.doi.org/10.3201/eid1804.111503
27. Doung-Ngern P, Chuxnum T, Pangjai D, Opaschaitat P, Kittiwan N, Rodtian P, et al. Seroprevalence of Coxiella burnetii antibodies among ruminants and occupationally exposed people in Thailand, 2012–2013. Am J Trop Med Hyg. 2017;96:786–90.
28. Li N, Yan LL, Niu W, Yao C, Feng X, Zhang J, et al. The effects of a community-based sodium reduction program in rural China—a cluster-randomized trial. PLoS One. 2016;11:e0166620. http://dx.doi.org/10.1371/journal.pone.0166620
29. Prasad N, Murdoch DR, Reyburn H, Crump JA. Etiology of severe febrile illness in low- and middle-income countries: a systematic review. PLoS One. 2015;10:e0127962. http://dx.doi.org/10.1371/journal.pone.0127962
30. Crump JA, Gove S, Parry CM. Management of adolescents and adults with febrile illness in resource-limited areas. BMJ. 2011;343:e4847. http://dx.doi.org/10.1136/bmj.d4847
31. Fields BS, House BL, Klena J, Waboci LW, Whistler T, Farnon EC. Role of Global Disease Detection laboratories in investigations of acute respiratory illness. J Infect Dis. 2013; 208(Suppl 3):S173–6. http://dx.doi.org/10.1093/infdis/jit490
32. Yasnoff WA, O’Carroll PW, Koo D, Linkins RW, Kilbourne EM. Public health informatics: improving and transforming public health in the information age. J Public Health Manag Pract. 2000;6:67–75. http://dx.doi.org/10.1097/00124784-200006060-00010
33. US Centers for Disease Control and Prevention. Protecting the nation’s health in an era of globalization: CDC’s global infectious disease strategy. Atlanta: The Centers; 2002.
34. US Centers for Disease Control and Prevention. Global Disease Detection stories: disease diplomacy—from China to Atlanta to Sierra Leone [cited 2015 Dec 11]. https://www.cdc.gov/globalhealth/healthprotection/gdd/stories/disease_diplomacy_china.html
35. He GX, Wang LX, Chai SJ, Klena JD, Cheng SM, Ren YL, et al. Risk factors associated with tuberculosis infection among health care workers in inner Mongolia, China. Int J Tuberc Lung Dis. 2012;16:1485–91. http://dx.doi.org/10.5588/ijtld.12.0193
36. Talaat M, El-Shokry M, El-Kholy J, Ismail G, Kotb S, Hafez S, et al. National surveillance of health care–associated infections in Egypt: developing a sustainable program in a resource-limited country. Am J Infect Control. 2016;44:1296–301. http://dx.doi.org/10.1016/j.ajic.2016.04.212